in Health care
Emcure, MSD get CDSCO Panel conditional nod to Manufacture, Market HIV drug Doravirine
New Delhi: Citing the unmet need, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug major MSD for a Phase III clinical trial waiver involving the retroviral drugs Doravirine tablet 100mg and Doravirine bulk drug in support of Emcure Pharmaceuticals’ proposal for manufacturing and marketing […] More
